相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ri sk factors and mechanisms of in vivo emergence of colistin resistance in carbapenem-resistant Klebsiella pneumoniae
Po-Han Huang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)
Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae
Yuan Tian et al.
MICROBIOLOGY SPECTRUM (2021)
Efficacy of tigecycline alone or in combination for experimental infections by KPC carbapenemase-producing Klebsiella pneumoniae
Sotiria Fergadaki et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2021)
Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant Organisms
Yaakov Dickstein et al.
CLINICAL INFECTIOUS DISEASES (2020)
A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections
Akosua A. Agyeman et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Molecular and Clinical Characterization of Multidrug-Resistant and Hypervirulent Klebsiella pneumoniae Strains from Liver Abscess in Taiwan
Yi-Tsung Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
The EMBL-EBI search and sequence analysis tools APIs in 2019
Fabio Madeira et al.
NUCLEIC ACIDS RESEARCH (2019)
Appropriate Treatment for Bloodstream Infections Due to Carbapenem-Resistant Klebsiella pneumoniae and Escherichia coli: A Nationwide Multicenter Study in Taiwan
Yi-Tsung Lin et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
A putative RND-type efflux pump, H239_3064, contributes to colistin resistance through CrrB in Klebsiella pneumoniae
Yi-Hsiang Cheng et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Emergence of an XDR and carbapenemase-producing hypervirulent Klebsiella pneumoniae strain in Taiwan
Yen-Hua Huang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Risk Factors for Colistin Resistance among Gram-Negative Rods and Klebsiella pneumoniae Isolates
Stefan E. Richter et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality
Laura J. Rojas et al.
CLINICAL INFECTIOUS DISEASES (2017)
Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes
Laurent Poirel et al.
CLINICAL MICROBIOLOGY REVIEWS (2017)
Amino Acid Substitutions of CrrB Responsible for Resistance to Colistin through CrrC in Klebsiella pneumoniae
Yi-Hsiang Cheng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
Yi-Yun Liu et al.
LANCET INFECTIOUS DISEASES (2016)
Colistin Resistance Mechanisms in Klebsiella pneumoniae Strains from Taiwan
Yi-Hsiang Cheng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study
D. R. Giacobbe et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
A. Capone et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
wzi Gene Sequencing, a Rapid Method for Determination of Capsular Type for Klebsiella Strains
Sylvain Brisse et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Isolation of a Bacteriophage Specific for a New Capsular Type of Klebsiella pneumoniae and Characterization of Its Polysaccharide Depolymerase
Chun-Ru Hsu et al.
PLOS ONE (2013)
Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
Zubair A. Qureshi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The Combination of Colistin and Doripenem Is Synergistic against Klebsiella pneumoniae at Multiple Inocula and Suppresses Colistin Resistance in an In Vitro Pharmacokinetic/Pharmacodynamic Model
Zakuan Z. Deris et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2012)
Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients
F. Kontopidou et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay
Spyros Pournaras et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
ISfinder: the reference centre for bacterial insertion sequences
P. Siguier et al.
NUCLEIC ACIDS RESEARCH (2006)
分享论文
